2026 ICD-10-CM Diagnosis Code Q78.5Metaphyseal dysplasia
ICD-10-CM Codes›Q00-Q99›Q65-Q79›Q78
- Billable — Valid for Submission
- POA Exempt
- Chronic Condition
Q78.5 is a billable ICD-10-CM diagnosis code for metaphyseal dysplasia. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 564 through 566. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Musculoskeletal congenital conditions.
Code Identity
Code Classification
Present on Admission (POA)Billing
Q78.5 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Acroscyphodysplasia
- Autosomal recessive spondylometaphyseal dysplasia Megarbane type
- Axial spondylometaphyseal dysplasia
- Bowing of upper limb
- Congenital maxillary hypoplasia
- Craniometaphyseal dysplasia
- Craniometaphyseal dysplasia - mild type
- Craniometaphyseal dysplasia - severe type
- Hypoplasia of maxillary bone
- Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomaly syndrome
- Kozlowski spondylometaphyseal dysplasia
- Lentiglobus
- Metaphyseal chondrodysplasia
- Metaphyseal chondrodysplasia, Jansen type
- Metaphyseal chondrodysplasia, McKusick type
- Metaphyseal chondrodysplasia, Schmid type
- Metaphyseal chondrodysplasia, Sedaghatian type
- Metaphyseal chondrodysplasia, Spahr type
- Metaphyseal dysplasia Braun Tinschert type
- Metaphyseal dysplasia, maxillary hypoplasia, brachydactyly syndrome
- Microphakia
- Microspherophakia
- Microspherophakia with metaphyseal dysplasia syndrome
- Osteosclerosis
- Osteosclerotic metaphyseal dysplasia
- Overgrowth, metaphyseal undermodeling, spondylar dysplasia syndrome
- Pyle metaphyseal dysplasia
- Regressive spondylometaphyseal dysplasia
- SBDS-related severe neonatal spondylometaphyseal dysplasia
- Spherophakia
- Spondyloenchondrodysplasia
- Spondylometaphyseal dysplasia
- Spondylometaphyseal dysplasia - Sutcliffe type
- Spondylometaphyseal dysplasia A4 type
- Spondylometaphyseal dysplasia, bowed forearms, facial dysmorphism syndrome
- Spondylometaphyseal dysplasia, corneal dystrophy syndrome
- Ulna metaphyseal dysplasia syndrome
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Pyle's syndrome
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Disease, diseased - See Also: Syndrome;
- Pyle (-Cohn) (metaphyseal dysplasia) - Q78.5
- Dysplasia - See Also: Anomaly;
- metaphyseal - Q78.5
- Pyle's syndrome - Q78.5
- Syndrome - See Also: Disease;
- Bakwin-Krida - Q78.5
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Bakwin-Krida syndrome(metaphyseal dysplasia)
- Disease, diseased
- Pyle (-Cohn) (metaphyseal dysplasia)
- Dysplasia
- metaphyseal
- Pyle's syndrome
- Syndrome
- Bakwin-Krida
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Osteopetrosis
excessive formation of dense trabecular bone leading to pathological fractures; osteitis; splenomegaly with infarct; anemia; and extramedullary hemopoiesis (hematopoiesis, extramedullary).Osteosclerosis
an abnormal hardening or increased density of bone tissue.Spherophakia
a congenital disorder of the eye where the lens is abnormally small and spherical.Weill-Marchesani Syndrome 1|Congenital Mesodermal Dysmorphodystrophy|Spherophakia-Brachymorphia Syndrome|Spherophakia-brachymorphia syndrome|Weill-Marchesani, Autosomal Recessive
an autosomal recessive subtype of weill-marchesani syndrome caused by mutations in the adamts10 gene, encoding a disintegrin and metalloproteinase with thrombospondin motifs 10.Osteosclerosis
abnormally high bone density.
Patient EducationClinical
Birth Defects
A birth defect is a problem that happens while a baby is developing in the mother's body. Most birth defects happen during the first 3 months of pregnancy. One out of every 33 babies in the United States is born with a birth defect.
The full article covers:
- What are birth defects?
- What causes birth defects?
- Who is at risk of having a baby with birth defects?
- How are birth defects diagnosed?
- What are the treatments for birth defects?
- Can birth defects be prevented?
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert Q78.5 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About Q78.5Overview
Is Q78.5 (Other osteochondrodysplasias) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report metaphyseal dysplasia on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does Q78.5 group to?
When metaphyseal dysplasia is the principal diagnosis on an inpatient stay, it groups to MS-DRG 564, 565, 566, with relative weights from 0.7493 to 1.5436 depending on complications. Higher weights mean higher Medicare reimbursement.
Is Q78.5 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for metaphyseal dysplasia on inpatient claims.
What is the ICD-9 equivalent of Q78.5?
Under the General Equivalence Mappings, metaphyseal dysplasia converts to ICD-9-CM 756.59 (osteodystrophy NEC). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
